Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type
Olivia Piccolo1,2, John D Lincoln3, Nicole Melong4
1Department of Biology, Dalhousie University, Halifax, NS, Canada.
Scientific Reports
|January 29, 2022
Summary
This study shows that a novel diamond target beam (DTB) combined with gold nanoparticles (GNPs) significantly enhances cancer cell killing and reduces tumor growth compared to standard radiotherapy, offering a promising new cancer treatment.
Area of Science:
- Medical Physics
- Oncology
- Nanotechnology
Background:
- Standard radiotherapy (RT) can damage healthy tissues, limiting its effectiveness.
- Gold nanoparticles (GNPs) can enhance RT efficacy, but clinical beams are inefficient for GNP interaction.
- Megavoltage beams are poor initiators of the photoelectric effect needed for GNP radiosensitization.
Purpose of the Study:
- To evaluate the efficacy of a novel diamond target beam (DTB) combined with gold nanoparticles (GNPs) for cancer treatment.
- To investigate GNP-enhanced radiosensitization using DTB radiation in preclinical models.
- To assess the potential of this approach for improving the therapeutic ratio in radiotherapy.
Main Methods:
- Computer modeling predicted increased low-energy photons with DTB for enhanced GNP interaction.
- In vitro studies tested DTB radiation with GNPs on head-and-neck cancer (HNC) cell lines.
- In vivo studies used zebrafish xenografts to assess cell-killing effects of DTB and GNPs.
Main Results:
- DTB radiation with GNPs significantly decreased HNC cell viability in vitro.
- Enhanced cell-killing and tumor reduction were observed in zebrafish xenografts.
- Increased double-stranded DNA breaks were detected in HNC cells with DTB and GNPs.
Conclusions:
- This study provides the first functional data supporting GNP-enhanced radiotherapy using a novel DTB.
- The DTB-GNP combination shows potential for optimizing radiotherapy efficacy, especially for difficult-to-treat tumors.
- This approach may improve the therapeutic ratio of radiation therapy by enhancing tumor cell death and reducing collateral damage.


